Alimera Sciences Inc
ALIMDelisted Sep 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267602
Alimera Sciences Inc was delisted on Sep 16, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 52 institutions reported holding it in 13F filings for Q2 2024, worth $257.9M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Alimera Sciences Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 25 | 27 | +2 |
| Shares | 1.96M | 1.96M | +1.72K (+0.1%) |
| Value | $17.9M | $8.29M | −$9.57M (−53.6%) |
New holders (5)
Institutions that held Alimera Sciences Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JPMorgan Chase & Co | 23,761 | $101.0K | 0.00% |
| Ensign Peak Advisors, Inc | 19,151 | $81.0K | 0.00% |
| Common Fund for Nonprofit Organizations | 11,969 | $50.5K | 0.01% |
| Blackstone Group Inc. | 10,612 | $45.0K | 0.00% |
| Advisor Group Holdings, Inc. | 15 | $0 | 0.00% |
Sold out (3)
Institutions that held Alimera Sciences Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Prelude Capital Management, LLC | 18,036 | $164.0K |
| PDT Partners, LLC | 17,723 | $161.0K |
| Marshall Wace, LLP | 13,086 | $119.0K |